reviewBloodSep 19, 2014BRONZE OA

Paroxysmal nocturnal hemoglobinuria

Johns Hopkins University · Johns Hopkins Medicine

PubMed
Indexed incrossrefpubmed

Abstract

Paroxysmal nocturnal hemoglobinuria (PNH) is a rare bone marrow failure disorder that manifests with hemolytic anemia, thrombosis, and peripheral blood cytopenias. The absence of two glycosylphosphatidylinositol (GPI)-anchored proteins, CD55 and CD59, leads to uncontrolled complement activation that accounts for hemolysis and other PNH manifestations. GPI anchor protein deficiency is almost always due to somatic mutations in phosphatidylinositol glycan class A (PIGA), a gene involved in the first step of GPI anchor biosynthesis; however, alternative mutations that cause PNH have recently been discovered. In addition, hypomorphic germ-line PIGA mutations that do not cause PNH have been shown to be responsible…

Citation impact

618
total citations
FWCI
15.39
Percentile
100%
References
91
Citations per year

Authors

1

Topics & keywords

Keywords
  • Paroxysmal nocturnal hemoglobinuria
  • Eculizumab
  • CD59
  • Hemoglobinuria
  • Immunology
  • Medicine
  • Hemolytic anemia
  • Bone marrow failure
UN Sustainable Development Goals
  • Good health and well-being
No related works found for this paper.

Funding